ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Apr 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
June 2026
Nuclear Technology
March 2026
Fusion Science and Technology
May 2026
Latest News
DOE selects first companies for nuclear launch pad
The Department of Energy’s Office of Nuclear Energy and the National Reactor Innovation Center have announced their first selections for the Nuclear Energy Launch Pad: three companies developing microreactors and one developing fuel supply.
The four companies—Deployable Energy, General Matter, NuCube Energy, and Radiant Industries—were selected from the initial pool of Reactor Pilot Program and Fuel Line Pilot Program applicants, the two precursor programs to the launch pad.
L. Lüdemann, R. Kampmann, W. Sosaat, P. Staron, P. Wille
Nuclear Science and Engineering | Volume 135 | Number 1 | May 2000 | Pages 57-63
Technical Paper | doi.org/10.13182/NSE00-A2124
Articles are hosted by Taylor and Francis Online.
A new irradiation facility, GBET (basic research on boron neutron capture therapy), especially designed for in vitro experiments on boron neutron capture therapy was put into operation at the Geesthacht Neutron Facility of the GKSS Research Center. Its location at a cold-neutron guide without direct view of the reactor core has two advantages: First, contamination of the primary beam with fast neutrons or photons is negligible. Second, GBET yields a high cold-neutron flux of 1.4 × 108/(cm2s) over an area of 3 × 4 cm. As a result of the energy dependence of the neutron absorption cross section of boron, this corresponds to a higher effective thermal flux of 4.7 × 108/(cm2s). This effect is used to reduce the irradiation times by a factor of 3.32.The effective flux is sufficient for irradiation of thin samples like cell monolayers in conventional culture flasks. For such in vitro irradiations, a survival fraction of 1% is achieved at a homogeneous boron concentration of 100 ppm 10B within ~20 min. Furthermore, the beam can be used for boron radiography. The respective experimental conditions are discussed, especially the neutron flux distribution, available for these different types of samples.